Showing results (11-20 of 288) with videos related to
Sort By:
Pageof 29
Oncotarget|January 5, 2018
New role of ID3 in melanoma adaptive drug-resistanceSachindra, Lionel Larribère, Daniel Novak, et al.International Journal of Cancer|August 16, 2018
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulationHuizi Wu, Lionel Larribère, Qian Sun, et al.Molecular Therapy Oncolytics|July 9, 2020
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant MelanomaAniello Federico, Tamara Steinfass, Lionel Larribère, et al.Pigment Cell & Melanoma Research|May 8, 2016
Multiple roles of NF1 in the melanocyte lineageLionel Larribère, Jochen UtikalClinical Epigenetics|November 24, 2018
Tackling malignant melanoma epigenetically: histone lysine methylationElias Orouji, Jochen UtikalEuropean Journal of Cell Biology|December 25, 2013
De- and re-differentiation of the melanocytic lineageLionel Larribere, Jochen UtikalExperimental Dermatology|May 19, 2011
From skin to the treatment of diseases--the possibilities of iPS cell research in dermatologyMarta Galach, Jochen UtikalMolecular Oncology|October 4, 2025
The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapyNina Wang, Qian Sun, Daniel Novak, et al.Cancers|February 25, 2022
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6Marlene Vierthaler, Qian Sun, Yiman Wang, et al.International Journal of Cancer|June 16, 2018
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanomaLaura Hüser, Sachindra Sachindra, Karol Granados, et al.Pageof 29